Regression analysis identified SREBF1 as an independent survival predictor in a multivariable model comprising the clinical tumor-node-metastasis (TNM) parameters (HR = 2.24, 95% CI = 1.36–3.71, P = 0.002) (Supplementary Table 2). Here, SREBF1 is linked to neoplasm.